288 related articles for article (PubMed ID: 33096754)
1. Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target.
Heesch A; Maurer J; Stickeler E; Beheshti M; Mottaghy FM; Morgenroth A
Cells; 2020 Oct; 9(10):. PubMed ID: 33096754
[TBL] [Abstract][Full Text] [Related]
2. GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs).
Lappano R; Maggiolini M
J Steroid Biochem Mol Biol; 2018 Feb; 176():49-56. PubMed ID: 28249728
[TBL] [Abstract][Full Text] [Related]
3. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
Salimifard S; Masjedi A; Hojjat-Farsangi M; Ghalamfarsa G; Irandoust M; Azizi G; Mohammadi H; Keramati MR; Jadidi-Niaragh F
Pathol Res Pract; 2020 May; 216(5):152915. PubMed ID: 32146002
[TBL] [Abstract][Full Text] [Related]
4. Fibroblasts in the Tumor Microenvironment.
Truffi M; Sorrentino L; Corsi F
Adv Exp Med Biol; 2020; 1234():15-29. PubMed ID: 32040852
[TBL] [Abstract][Full Text] [Related]
5. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets.
Lappano R; Rigiracciolo DC; Belfiore A; Maggiolini M; De Francesco EM
Expert Opin Ther Targets; 2020 Jun; 24(6):559-572. PubMed ID: 32249708
[No Abstract] [Full Text] [Related]
6. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis.
Tashireva LA; Denisov EV; Gerashchenko TS; Pautova DN; Buldakov MA; Zavyalova MV; Kzhyshkowska J; Cherdyntseva NV; Perelmuter VM
Immunobiology; 2017 Apr; 222(4):631-640. PubMed ID: 27916281
[TBL] [Abstract][Full Text] [Related]
8. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
9. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
Plava J; Cihova M; Burikova M; Matuskova M; Kucerova L; Miklikova S
Mol Cancer; 2019 Mar; 18(1):67. PubMed ID: 30927930
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer.
Hill BS; Sarnella A; D'Avino G; Zannetti A
Semin Cancer Biol; 2020 Feb; 60():202-213. PubMed ID: 31377307
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts in cancer: Defining target structures for therapeutic intervention.
Boesch M; Baty F; Rumpold H; Sopper S; Wolf D; Brutsche MH
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):111-121. PubMed ID: 31265878
[TBL] [Abstract][Full Text] [Related]
15. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
Houthuijzen JM; Jonkers J
Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
18. Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.
Barone I; Vircillo V; Giordano C; Gelsomino L; Győrffy B; Tarallo R; Rinaldi A; Bruno G; Caruso A; Romeo F; Bonofiglio D; Andò S; Catalano S
Cancer Lett; 2018 Nov; 437():89-99. PubMed ID: 30176263
[TBL] [Abstract][Full Text] [Related]
19. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
[TBL] [Abstract][Full Text] [Related]
20. Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
Blanchette-Farra N; Kita D; Konstorum A; Tesfay L; Lemler D; Hegde P; Claffey KP; Torti FM; Torti SV
Oncogene; 2018 Jul; 37(29):4013-4032. PubMed ID: 29695834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
